Peter Welch said...
to limit the drugs placed in limited distribution networks to only the REMS drugs.
Context
Welch suggests restricting limited distribution networks to safety-focused drugs.
03/21/2017
Welch suggests restricting limited distribution networks to safety-focused drugs.
03/21/2017